Conventional- versus high-dose vancomycin regimen in patients with acute bacterial meningitis: a randomized clinical trial

Bibliography

• Eshenauer GA, Potoski BA, Dudas VJ. Central nervous system infections. In: Kimble K, Youngs, editors. Applied therapeutics, the clinical use of drugs. 10th edition. Williams & Wilkins; Lippincott: 2012. p. 1468-88
   Google Scholar
• Beek DV, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet 2012;380:1693-23
   PubMed Web of Science ®Google Scholar
• Tunkel AR, Hartman BJ, Kaplan SL, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis 2004;39(9):126712-84
   Web of Science ®Google Scholar
• Dipiro JT, Talbert RL, Yee GC, et al. Pharmacotherpay: a phatophysiologic approach. 7th edition. Medicinal Publishing Division; New York: 2012. p. 1743-61
   Google Scholar
• Ricard JD, Wolff M, Lacherade JC, et al. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study. Clin Infect Dis 2007;44(2):250-5
   PubMed Web of Science ®Google Scholar
• Rybak MJ, Lomaestro BM, Rotschafer JC, et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009;49(3):325-7
   PubMed Web of Science ®Google Scholar
• Chen Y, Feng J, Li B, et al. Estimation of safe and effective dose of vancomycin in MRSA-infectied patients using serum cystatin C concentrations. Int J Clin Pharmacol Ther 2013;51(3):161-9
   PubMed Web of Science ®Google Scholar
• Hidayat LK, Hsu DI, Quist R, et al. High-dose vancomycin therapy for methicillin-resistant staphylococcus aureus infections. Arch Intern Med 2006;166:2138-44
   PubMed Web of Science ®Google Scholar
• Pritchard L, Baker C, Leggett J, et al. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. Am J Med 2010;123:1143-9
   PubMed Web of Science ®Google Scholar
• Hazlewood KA, Brouse SD, Pitcher WD, Hall RG. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination? Am J Med 2010;123(2):182; e1-7
   PubMed Web of Science ®Google Scholar
• Cheong JY, Makmor-Bakry M, Lau CL, Abdul Rahman R. The relationship between trough concentration of vancomycin and effect on methicillin-resistant Staphylococcus aureus in critically ill patients. S Afr Med J 2012;102(7):616-19
   PubMed Web of Science ®Google Scholar
• Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet 1974;2:81-4
   PubMed Web of Science ®Google Scholar
• Merkelbach S, Rohn S, Konig J, Muller M. Usefulness of clinical score to predict outcome in bacterial meningitis. Infecion 1999;27(4):239-43
   PubMed Web of Science ®Google Scholar
• Elyasi S, Khalili H, Dashti-Khavidaki S, Mohammadpour A. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 2012;68(9):1243-55
   PubMed Web of Science ®Google Scholar
• Davis SL, Scheetz MH, Bosso JA, et al. Adherence to the 2009 consensus guidelines for vancomycin dosing and monitoring practices: a cross-sectional survey of U.S. hospitals. Pharmacotherapy 2013;33(12):1256-63
   PubMed Web of Science ®Google Scholar
• Bosso JA, Nappi J, Rudisill C, et al. Relationship between vancomycin trough concentrations and nephrotoxicity: a prospective multicenter trial. Antimicrob Agents Chemother 2011;55:5475-9
   PubMed Web of Science ®Google Scholar
• Modi S, Anand AK. Phenotypic characterization and antibiogram of CSF isolates in acute bacterial meningitis. J Clin Diagn Res 2013;7(12):2704-8
   PubMedGoogle Scholar
• Erdem H, Elaldi N, Öztoprak N, et al. Mortality indicators in pneumococcal meningitis: therapeutic implications. Int J Infect Dis 2014;19:13-19
   PubMed Web of Science ®Google Scholar
• Hofinger D, Davis LE. Bacterial meningitis in older adults. Curr Treat Options Neurol 2013;15(4):477-91
   PubMed Web of Science ®Google Scholar
• American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416
   PubMed Web of Science ®Google Scholar
• Chaudhary M, Shrivastava SM, Sehgal R. Efficacy and safety study of fixed-dose combination of ceftriaxone-vancomycin injection in patients with various infections. Curr Drug Saf 2008;3(1):82-5
   PubMedGoogle Scholar
• Kullar R, Leonard SN, Davis SL, et al. Validation of the effectiveness of vancomycib nomogrm in achieving target trough concentrations of 15-20 mg/L suggested by the vancomycib consensus guidelines. Pharmacotherapy 2011;31(5):441-8
   PubMed Web of Science ®Google Scholar
• Zimmermann AE, Katona BG, Plaisance KI. Association of vancomycin serum concentrations with outcomes in patients with grampositive bacteremia. Pharmacotherapy 1995;15:85-91
   PubMed Web of Science ®Google Scholar
• Ackerman BH, Vannier AM, Eudy EB. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob Agents Chemother 1992;36:1766-9
   PubMed Web of Science ®Google Scholar
• Lodise TP, Patel N, Lomaestro BM, et al. Relationship between initial vancomycin concentrationtime profile and nephrotoxicity. Clin Infect Dis 2009;49:507-14
   PubMed Web of Science ®Google Scholar
• Huanga LY, Wanga CY, Jangb TN, Yeh HL. Nephrotoxicity of vancomycin and teicoplanin alone and in combination with an aminoglycoside. Taiwan Pharm J 2007;59:1-8
   Google Scholar
• Krcméry VJ, Fuchsberger P, Gocár M, et al. Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients. Chemotherapy 1991;37:287-91
   PubMed Web of Science ®Google Scholar
• Cimino MA, Rotstein C, Slaughter RL, Emrich LJ. Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy. Am J Med 1987;83:1091-7
   PubMed Web of Science ®Google Scholar
• Wan Y. Link between initial vancomycin concentrationtime profile and nephrotoxicity in hospitalised patients. Clin Infect Dis 2009;49:507-14
   PubMedGoogle Scholar